More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.62B
EPS
2.43
P/E ratio
15.7
Price to sales
1.02
Dividend yield
1.206%
Beta
0.426725
Previous close
$39.25
Today's open
$39.37
Day's range
$39.28 - $40.87
52 week range
$28.25 - $60.08
show more
CEO
Jack Clifford Bendheim
Employees
1940
Headquarters
Teaneck, NJ
Exchange
NASDAQ Global Market
Shares outstanding
40601603
Issue type
Common Stock
Healthcare
Pharmaceuticals
Will Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report?
Phibro (PAHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks Investment Research • 10 hours ago

PAHC or SYK: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
Zacks Investment Research • Oct 21, 2026

Is it the Right Time to Add Phibro Stock to Your Portfolio?
PAHC's Animal Health gains from MFA, vaccine and mineral nutrition growth, but tariffs, costs and currency swings remain key risks to its outlook.
Zacks Investment Research • Oct 8, 2026

PAHC vs. HAE: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?
Zacks Investment Research • Oct 5, 2026

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Sep 28, 2026

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Sep 25, 2026

Best Momentum Stocks to Buy for September 21st
SEI, SDRL and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 21st, 2026.
Zacks Investment Research • Sep 21, 2026

PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?
Zacks Investment Research • Sep 18, 2026

Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Sep 17, 2026

4 Stocks With Strong Interest Coverage to Buy as Yields Rise
DiamondRock Hospitality, Vertiv, Mueller Water Products and Phibro Animal Health stand out for strong interest coverage as Treasury yields rise.
Zacks Investment Research • Sep 16, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Phibro Animal Health Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.